Drug Type Small molecule drug |
Synonyms 3-bromo-5-phenylsalicylic acid |
Target |
Mechanism AKR1C1 inhibitors(aldo-keto reductase family 1 member C1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC13H9BrO3 |
InChIKeyXVZSXNULHSIRCQ-UHFFFAOYSA-N |
CAS Registry4906-68-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | AU | 28 May 2009 | |
Nervous System Diseases | Preclinical | AU | 28 May 2009 |